ANI Pharmaceuticals
ANIP
#5234
Rank
NZ$3.02 B
Marketcap
NZ$131.66
Share price
2.65%
Change (1 day)
-16.99%
Change (1 year)

EPS for ANI Pharmaceuticals (ANIP)

EPS in 2026 (TTM): NZ$8.39

According to ANI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ$8.61. In 2025 the company made an earnings per share (EPS) of NZ$6.24 an increase over its 2024 EPS that were of NZ-$2.00.

EPS history for ANI Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$8.3934.54%
2025NZ$6.24-412.5%
2024NZ-$2.00
2022NZ-$5.42-6.46%
2021NZ-$5.7972.87%
2020NZ-$3.35-476%
2019NZ$0.89-62.12%
2018NZ$2.35
2015NZ$2.39-47.66%
2014NZ$4.56-142.11%
2013NZ-$10.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$11.87 37.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.35-84.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
NZ$12.94 50.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
NZ$27.17 215.73%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
NZ-$4.49-152.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$7.75-190.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$1.12-86.96%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Royalty Pharma
RPRX
NZ$3.34-61.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
NZ-$45.05-623.40%๐Ÿ‡บ๐Ÿ‡ธ USA